HSV-2 Biochip concerns the evaluation of an innovative HSV-2 antibody biosensor designed & developed at MiCRA Biodiagnostics for use in PoC immunoassay devices & mobile bio-analytical systems. The chip R&D & clinical analysis under review will correlate the biosensor response against known positive and negative human serum samples held by a commercial reference laboratory, viz Cerba Specimen Servi (Q233162)

From EU Knowledge Graph
Revision as of 12:42, 1 February 2020 by DG Regio (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Project in Ireland financed by DG Regio
Language Label Description Also known as
English
HSV-2 Biochip concerns the evaluation of an innovative HSV-2 antibody biosensor designed & developed at MiCRA Biodiagnostics for use in PoC immunoassay devices & mobile bio-analytical systems. The chip R&D & clinical analysis under review will correlate the biosensor response against known positive and negative human serum samples held by a commercial reference laboratory, viz Cerba Specimen Servi
Project in Ireland financed by DG Regio

    Statements

    0 references
    7,683.84 Euro
    0 references
    15,367.68 Euro
    0 references
    50.0 percent
    0 references
    27 July 2015
    0 references
    26 December 2015
    0 references
    Institute of Technology, Tallaght
    0 references
    HSV-2 Biochip concerns the evaluation of an innovative HSV-2 antibody biosensor designed & developed at MiCRA Biodiagnostics for use in PoC immunoassay devices & mobile bio-analytical systems. The chip R&D & clinical analysis under review will correlate the biosensor response against known positive and negative human serum samples held by a commercial reference laboratory, viz Cerba Specimen Services, Paris. (English)
    0 references

    Identifiers

    119
    0 references